Evidence map›Paper›PMID 40483545›Full record

ArticleBriefings in bioinformatics2025

RPSubAlign: a novel sequence-based molecular representation method for retrosynthesis prediction with improved validity and robustness.

Yuting Hu, Feng Hu, Hongwen Zhang, Hongling Xu, Jixiang Gao, Wenshuai Deng, Zijing Tian, Qiaoyu Hu, Honglin Li, Yanyan Diao

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuting HuShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.ORCID 0009-0007-1812-0958
Feng HuShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Hongwen ZhangShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Hongling XuShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.ORCID 0000-0003-2270-1900
Jixiang GaoShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Wenshuai DengShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Zijing TianShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Qiaoyu HuInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, 3663 North Zhongshan Road, Putuo District, Shanghai 200062, China.
Honglin LiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
Yanyan DiaoInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, 3663 North Zhongshan Road, Putuo District, Shanghai 200062, China.

Funding

National Key Research and Development Program of China 2022YFC3400501National Key Research and Development Program of China 2022YFC3400504National Natural Science Foundation of China 82404517National Natural Science Foundation of China 82425104Science and Technology Commission of Shanghai Municipality 24JS2830200
6 · The paper itself

Abstract

Retrosynthetic route planning is essential for designing efficient pathways to synthesize complex molecules, serving as a cornerstone in drug discovery and organic synthesis. Sequence-based models have become a predominant approach in retrosynthetic route planning, yet its validity and robustness remain limited by the challenges in molecular representation methods. Current methods typically treat reactants and products as independent molecules, overlooking structural relationships crucial for accurate synthesis predictions. Herein, we introduce RPSubAlign, a molecular sequence representation method specifically tailored for retrosynthetic tasks, which aligns common substructures between reactants and products to enhance the validity and robustness of sequence-based models. Compared with conventional random and root-alignment representations, RPSubAlign achieves better performance on the USPTO-50K and USPTO-MIT datasets, improving up to a 34.8% increase in Top-N accuracy (with Self-Referencing Embedded Strings representation) and demonstrating enhanced stability across various data augmentation scenarios. RPSubAlign significantly improves syntactic validity, reaching 86.64% on USPTO-50K and 96.45% on USPTO-MIT (with Simplified Molecular Input Line Entry System representation), outperforming baseline methods. These results highlight RPSubAlign as a robust, effective approach for molecular characterization method for retrosynthesis predictions. Code for RPSubAlign is available at https://github.com/Aminoacid1226/RPSubAlign.

Indexed as

AlgorithmsComputational BiologyDrug DiscoverySoftwarecomputer-aided synthesis planningdeep learningmolecular representation

Identifiers

PMID40483545
PMCPMC12145223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.